Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
US Department of Justice
Covington
Boehringer Ingelheim
Express Scripts
Merck
Mallinckrodt
Baxter
McKinsey

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,254,539

« Back to Dashboard

Summary for Patent: 5,254,539
Title: Method of treating HIV with 2',3'-dideoxyinosine
Abstract:A method for tearing retroviral infections including acquired immune deficiency syndrome (AIDS) with 2',3'-dideoxyinosine or 2',3'-dideoxyadenosine is disclosed. This antiviral effect is irreversible with 2',3'-dideoxyinosine and 2',3'-dideoxyadenosine but reversible with 2',3'-dideoxyguanosine.
Inventor(s): Mitsuya; Hiroaki (Rockville, MD), Broder; Samuel (Bethesda, MD)
Assignee: U.S. Government, Dept. of Health and Human Services, c/o National (Bethesda, MD)
Application Number:07/663,288
Patent Claim Types:
see list of patent claims
Use; Delivery;

Drugs Protected by US Patent 5,254,539

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 5,254,539

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 96325 ➤ Try a Free Trial
Australia 570853 ➤ Try a Free Trial
Australia 5832990 ➤ Try a Free Trial
Australia 6196886 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Cerilliant
Johnson and Johnson
Express Scripts
Merck
Citi
AstraZeneca
Cantor Fitzgerald
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.